Anyone who would compare a company like SRNE that
Post# of 72440
and basing that on PRELIMINARY non-animal testing --
and then IPIX with its successful clinical trials --
well, that should tell you all you need to know about that poster.
Imagine how the multi-identities would be screaming if Mr. Ehrlich came out with such a bogus statement, obviously intended to deceive -- and yet the CEO of SRNE is given a pass, and the claim is that their cash position is why their stock price is where it is.
At least we're getting the compliment of having a long-time identity post this, instead of one of the newer ones.